New norovirus vaccine approach may help treat other RNA viruses
Base to Base biotech podcast 72: Cell-free DNA bioproduction
KTU chemists develop dual-action compounds to fight cancer
RSV antiviral drug receives FDA approval for phase II trial
Base to Base biotech podcast 61: Making tumours visible, and taking on tough challenges
Paediatric pneumococcal vaccine programme advancing
FDA clearance for universal dual-target CAR-T candidate
Positive data from chronic scrotal content pain trial
Thalassaemia treatment gets EU approval
New data from Parkinson’s disease trial
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial